Status:
COMPLETED
Symptomatic Efficacy of Diacerein in Knee Osteoarthritis
Lead Sponsor:
Laboratoires NEGMA
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Pain is the main symptom of osteoarthritis that motivates medical visits. Diacerhein has already demonstrated its efficacy in knee and/or hip osteoarthritis. This study aims at confirming the efficacy...
Eligibility Criteria
Inclusion
- Painful primary osteoarthritis (VAS ≥ 40 mm)
- Radiologically proven (Kellgren \& Lawrence grade I to III)
- Requiring the prescription of a symptomatic treatment of pain
Exclusion
- Severe associated diseases
- Wash-out: AINS, Coxibs, Paracetamol, anti-osteoarthritic treatments, hyaluronic acid, knee tidal lavage
- Other osteoarticular disease
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
End Date :
September 1 2006
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00445276
Start Date
November 1 2005
End Date
September 1 2006
Last Update
March 4 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Trousseau
Tours, France, 37044